:@0.060472:0.059082:0.160693:0.059082:0.160693:0.043805:0.060472:0.043805:0.006249:0.006249:0.006249:0.006249:0.006249:0.006249:0.006249:0.006249:0.006434:0.006249:0.006249:0.006249:0.006249:0.006249:0.006249:0.006305
CAVITE STATE UNIVERSITY   :@0.160693:0.059336:0.490711:0.059336:0.490711:0.042731:0.160693:0.042731:0.014916:0.014513:0.014695:0.008063:0.014110:0.014513:0.006853:0.013485:0.014110:0.014513:0.014110:0.014513:0.006853:0.014916:0.014916:0.008063:0.014695:0.014513:0.015723:0.013304:0.008063:0.014110:0.014013:0.006853:0.018746:0.006853
 :@0.544329:0.058001:0.548304:0.058001:0.548304:0.048370:0.544329:0.048370:0.003975
                                                  :@0.060472:0.076055:0.271926:0.076055:0.271926:0.063077:0.060472:0.063077:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004233:0.004036:0.004233:0.004233
Tanza :@0.271955:0.076796:0.334039:0.076796:0.334039:0.059493:0.271955:0.059493:0.008466:0.013304:0.012094:0.009272:0.013304:0.005644
 :@0.334089:0.076559:0.339282:0.076559:0.339282:0.060640:0.334089:0.060640:0.005193
 :@0.060472:0.092645:0.064663:0.092645:0.064663:0.079532:0.060472:0.079532:0.004191
1 :@0.929416:0.941437:0.944852:0.941437:0.944852:0.926816:0.929416:0.926816:0.010280:0.005155
 :@0.060472:0.957070:0.064663:0.957070:0.064663:0.943957:0.060472:0.943957:0.004191
 :@0.060472:0.107966:0.065627:0.107966:0.065627:0.093345:0.060472:0.093345:0.005155
Name of Students:@0.069542:0.130486:0.217566:0.130486:0.217566:0.115865:0.069542:0.115865:0.013297:0.010311:0.015448:0.010311:0.005230:0.010070:0.005230:0.005230:0.012295:0.005230:0.010311:0.010255:0.010070:0.010311:0.005155:0.009272
 :@0.217530:0.130486:0.222685:0.130486:0.222685:0.115865:0.217530:0.115865:0.005155
::@0.252402:0.130486:0.257557:0.130486:0.257557:0.115865:0.252402:0.115865:0.005155
  Asido, Annsherina G. :@0.257441:0.130486:0.466638:0.130486:0.466638:0.115865:0.257441:0.115865:0.005155:0.010970:0.012907:0.010459:0.005230:0.011331:0.011238:0.005230:0.005415:0.012907:0.011331:0.011238:0.010311:0.011257:0.010311:0.007214:0.005230:0.011331:0.010237:0.005230:0.014317:0.005195:0.005155
Daligcon, Geldain L. :@0.273567:0.145451:0.456358:0.145451:0.456358:0.130830:0.273567:0.130830:0.013297:0.010311:0.005155:0.005285:0.011331:0.010237:0.011331:0.011238:0.005044:0.005044:0.014502:0.010311:0.005155:0.011331:0.010088:0.005230:0.011331:0.005155:0.011127:0.005133:0.005155
Morada, Jofhel D. :@0.273567:0.160560:0.432774:0.160560:0.432774:0.145939:0.273567:0.145939:0.015503:0.011331:0.007214:0.010311:0.011257:0.010070:0.005230:0.005230:0.010311:0.011053:0.006231:0.011331:0.010237:0.005044:0.005230:0.013297:0.005175:0.005155
Turla, Maria Niña M. :@0.273567:0.175525:0.453335:0.175525:0.453335:0.160905:0.273567:0.160905:0.011090:0.011331:0.007214:0.005230:0.010311:0.005155:0.005100:0.015503:0.010311:0.007214:0.005230:0.010070:0.005230:0.013297:0.005230:0.011331:0.010033:0.005230:0.015318:0.005188:0.005155
Group :@0.069542:0.190634:0.126139:0.190634:0.126139:0.176013:0.069542:0.176013:0.014502:0.006231:0.010311:0.010255:0.010142:0.005155
: :@0.252402:0.190634:0.262597:0.190634:0.262597:0.176013:0.252402:0.176013:0.005039:0.005155
Group 6 :@0.273567:0.190634:0.349525:0.190634:0.349525:0.176013:0.273567:0.176013:0.014502:0.007214:0.011331:0.011331:0.011053:0.005230:0.010143:0.005155
Year and Section :@0.069542:0.205600:0.216437:0.205600:0.216437:0.190979:0.069542:0.190979:0.012295:0.010311:0.010255:0.006231:0.005230:0.010311:0.010255:0.010311:0.005155:0.012369:0.010311:0.009013:0.005230:0.004024:0.010311:0.010127:0.005155
: :@0.252402:0.205600:0.262597:0.205600:0.262597:0.190979:0.252402:0.190979:0.005039:0.005155
BSBM 3-1 :@0.273567:0.205600:0.365046:0.205600:0.365046:0.190979:0.273567:0.190979:0.013297:0.012295:0.013297:0.015503:0.005230:0.010375:0.006249:0.010079:0.005155
Instructor:@0.069542:0.220565:0.146633:0.220565:0.146633:0.205945:0.069542:0.205945:0.005230:0.010311:0.009272:0.005007:0.006231:0.010311:0.009272:0.005155:0.010125:0.006175
 :@0.146583:0.220565:0.151739:0.220565:0.151739:0.205945:0.146583:0.205945:0.005155
::@0.252402:0.220565:0.257557:0.220565:0.257557:0.205945:0.252402:0.205945:0.005155
  RITCH M. BANATE, MBA :@0.257441:0.220565:0.495262:0.220565:0.495262:0.205945:0.257441:0.205945:0.005155:0.010970:0.013297:0.005230:0.011090:0.013297:0.013297:0.005230:0.015503:0.005230:0.005230:0.013482:0.012703:0.013686:0.013111:0.011331:0.012258:0.005230:0.005230:0.015503:0.013111:0.013494:0.005155
 :@0.060472:0.235674:0.065627:0.235674:0.065627:0.221053:0.060472:0.221053:0.005155
 :@0.060472:0.258194:0.065627:0.258194:0.065627:0.243573:0.060472:0.243573:0.005155
 :@0.120984:0.280714:0.126139:0.280714:0.126139:0.266093:0.120984:0.266093:0.005155
 :@0.120984:0.303234:0.126139:0.303234:0.126139:0.288613:0.120984:0.288613:0.005155
 :@0.060472:0.325754:0.065627:0.325754:0.065627:0.311133:0.060472:0.311133:0.005155
Historically,  the  pharmaceutical  industry  has  been  a  profitable  one.  Between  2002  and  2006  the :@0.120984:0.348309:0.944385:0.348309:0.944385:0.333688:0.120984:0.333688:0.013297:0.004024:0.009272:0.005230:0.010311:0.006175:0.004117:0.009272:0.010237:0.004024:0.004024:0.009068:0.005230:0.005155:0.002893:0.005230:0.010311:0.010255:0.005155:0.002893:0.010311:0.010255:0.010311:0.006175:0.015540:0.010070:0.009272:0.010311:0.010255:0.005230:0.004024:0.009272:0.010311:0.004006:0.005155:0.002893:0.004024:0.010311:0.010255:0.010311:0.009272:0.005155:0.006287:0.009068:0.005155:0.002893:0.010311:0.010255:0.009272:0.005155:0.002893:0.010311:0.010051:0.010311:0.010255:0.005155:0.002893:0.010311:0.005155:0.002856:0.010311:0.006175:0.010125:0.005415:0.004024:0.005230:0.010311:0.010255:0.004024:0.010311:0.005155:0.002856:0.010311:0.010255:0.010070:0.005230:0.005155:0.002893:0.012295:0.010311:0.005007:0.013111:0.010311:0.010255:0.010311:0.005155:0.002856:0.010311:0.010255:0.010311:0.010255:0.005155:0.002893:0.010311:0.010255:0.010311:0.005155:0.002856:0.010311:0.010255:0.010311:0.010255:0.005155:0.002893:0.005230:0.010311:0.010255:0.005155
average rate of return on invested capital (ROIC) for firms in the industry was 16.45%. Put differently, for :@0.060472:0.370972:0.944153:0.370972:0.944153:0.356351:0.060472:0.356351:0.010311:0.009031:0.010311:0.006175:0.010311:0.010478:0.010311:0.006686:0.006231:0.010311:0.005155:0.010125:0.006843:0.010070:0.005230:0.006639:0.006231:0.010070:0.005230:0.010311:0.006175:0.010125:0.006843:0.010070:0.010311:0.006806:0.004024:0.010311:0.009031:0.010311:0.009272:0.005155:0.010311:0.010311:0.006824:0.009272:0.010311:0.010255:0.004024:0.005230:0.010311:0.003802:0.006843:0.006231:0.013111:0.014502:0.005230:0.013111:0.006231:0.006639:0.005230:0.010311:0.006009:0.006639:0.005415:0.003839:0.006231:0.015503:0.009068:0.006843:0.004024:0.010070:0.006843:0.005230:0.010311:0.010051:0.006843:0.004024:0.010311:0.010255:0.010311:0.009272:0.005007:0.006231:0.009068:0.006843:0.013111:0.010311:0.009272:0.006806:0.010311:0.010255:0.005230:0.010311:0.010051:0.016486:0.005081:0.006843:0.012295:0.010311:0.005007:0.006843:0.010311:0.003802:0.005230:0.005230:0.010311:0.006009:0.010311:0.010255:0.005230:0.004024:0.009068:0.005230:0.006639:0.005415:0.010070:0.006045:0.005155
every dollar of capital invested in the industry, the average pharmaceutical firm generated 16.45 cents of :@0.060472:0.393492:0.944106:0.393492:0.944106:0.378871:0.060472:0.378871:0.010311:0.009031:0.010311:0.006175:0.009105:0.007028:0.010311:0.010255:0.004024:0.004024:0.010311:0.006175:0.007084:0.010070:0.005415:0.006843:0.009272:0.010311:0.010255:0.004024:0.005230:0.010311:0.004006:0.007028:0.004024:0.010070:0.009068:0.010311:0.009272:0.005155:0.010311:0.010311:0.007028:0.004024:0.010311:0.006806:0.005230:0.010311:0.010255:0.007028:0.004024:0.010311:0.010255:0.010311:0.009031:0.005230:0.006231:0.009068:0.005044:0.007028:0.005044:0.010311:0.010255:0.007028:0.010311:0.009031:0.010311:0.006175:0.010311:0.010478:0.010070:0.007028:0.010311:0.010255:0.010070:0.006231:0.015503:0.010070:0.009272:0.010311:0.010255:0.005230:0.003839:0.009272:0.010311:0.004006:0.006843:0.005415:0.004024:0.006045:0.015318:0.006843:0.010459:0.010311:0.010255:0.010311:0.006175:0.010125:0.005230:0.010311:0.010255:0.007028:0.010311:0.010051:0.005230:0.010311:0.010051:0.007028:0.009272:0.010311:0.010255:0.005044:0.009272:0.007028:0.010070:0.005044:0.005155
profit. This compares with an average return on invested capital of 12.76% for firms in the computer hardware :@0.060472:0.416011:0.944535:0.416011:0.944535:0.401391:0.060472:0.401391:0.010311:0.006175:0.010125:0.005415:0.004024:0.005044:0.005230:0.004024:0.011479:0.010311:0.004006:0.009272:0.004228:0.009272:0.010311:0.015448:0.010311:0.010088:0.006231:0.010311:0.009272:0.004210:0.013111:0.004024:0.005230:0.010311:0.004210:0.010311:0.010255:0.004228:0.010311:0.009031:0.010311:0.006175:0.010311:0.010478:0.010311:0.004210:0.006231:0.010070:0.005230:0.010311:0.006175:0.010311:0.004247:0.010311:0.010255:0.004435:0.004024:0.010070:0.009068:0.010311:0.009272:0.005155:0.010311:0.010311:0.004228:0.009272:0.010311:0.010255:0.004024:0.005230:0.010311:0.004006:0.004228:0.010070:0.005415:0.004228:0.010311:0.010255:0.005230:0.010311:0.010051:0.016486:0.004080:0.005230:0.010311:0.006175:0.004080:0.005415:0.003839:0.006231:0.015503:0.009068:0.004228:0.004024:0.010311:0.004210:0.005230:0.010311:0.010255:0.004228:0.009272:0.010070:0.015503:0.010311:0.010255:0.005230:0.010070:0.006231:0.004024:0.010311:0.010255:0.006231:0.010311:0.013074:0.010311:0.006175:0.010311:0.005155
industry, 8.54% for grocers, and 3.88% for firms in the electronics industry. However, the average level of :@0.060472:0.438531:0.944031:0.438531:0.944031:0.423911:0.060472:0.423911:0.004024:0.010311:0.010255:0.010311:0.009272:0.005155:0.006287:0.009068:0.005230:0.006435:0.010070:0.005230:0.010311:0.010255:0.016319:0.006231:0.005415:0.010070:0.006231:0.006231:0.010311:0.006175:0.010311:0.009087:0.010311:0.006175:0.009272:0.005081:0.006435:0.010311:0.010255:0.010311:0.006398:0.010070:0.005230:0.010311:0.010255:0.016319:0.006231:0.005415:0.010070:0.006231:0.006231:0.005415:0.003839:0.006045:0.015503:0.009068:0.006435:0.004024:0.010311:0.006398:0.005230:0.010311:0.010051:0.006435:0.010311:0.004006:0.010311:0.009272:0.005155:0.006101:0.010311:0.010255:0.004024:0.009272:0.009272:0.006435:0.004024:0.010311:0.010255:0.010311:0.009272:0.005007:0.006231:0.009068:0.005230:0.006435:0.013297:0.010311:0.013074:0.010459:0.009068:0.010311:0.006175:0.005267:0.006435:0.005230:0.010311:0.010051:0.006435:0.010311:0.009031:0.010311:0.006175:0.010125:0.010311:0.010255:0.006435:0.004024:0.010311:0.009031:0.010311:0.004006:0.006435:0.010311:0.005155:0.005155
profitability  in the  pharmaceutical  industry  has  been  declining  of  late.  In  2002, the  average  ROIC  in the :@0.060472:0.461051:0.944674:0.461051:0.944674:0.446431:0.060472:0.446431:0.010311:0.006175:0.010125:0.005415:0.004024:0.005230:0.010311:0.010255:0.004024:0.004024:0.004024:0.005230:0.009068:0.005155:0.002893:0.004024:0.010311:0.007807:0.005230:0.010311:0.010051:0.005155:0.002893:0.010311:0.010255:0.010311:0.006009:0.015318:0.010311:0.009272:0.010255:0.010311:0.005155:0.004117:0.009272:0.010255:0.004024:0.005155:0.002893:0.004024:0.010311:0.010255:0.010311:0.009272:0.005007:0.006231:0.009068:0.005155:0.002893:0.010311:0.010255:0.009068:0.005155:0.002893:0.010070:0.010311:0.010255:0.010311:0.005155:0.002856:0.010311:0.010255:0.009272:0.004024:0.004024:0.010311:0.004006:0.010311:0.010255:0.005155:0.002893:0.010070:0.005230:0.005155:0.002893:0.004024:0.010070:0.005230:0.010311:0.005007:0.005155:0.002893:0.005230:0.010070:0.005155:0.002893:0.010311:0.010255:0.010311:0.010255:0.005044:0.007844:0.005230:0.010311:0.010051:0.005155:0.003387:0.010311:0.009031:0.010311:0.006175:0.010311:0.010478:0.010070:0.005155:0.002893:0.013111:0.014502:0.005044:0.013297:0.005155:0.002893:0.004024:0.010311:0.007807:0.005230:0.010070:0.010070:0.005155
industry was 21.6%; by 2006, it had fallen to 14.5%. :@0.060472:0.483571:0.490021:0.483571:0.490021:0.468950:0.060472:0.468950:0.004024:0.010311:0.010255:0.010311:0.009272:0.005155:0.006287:0.009068:0.005230:0.013111:0.010311:0.009272:0.005155:0.010311:0.010311:0.005211:0.010311:0.016301:0.005230:0.005230:0.010311:0.009031:0.005230:0.010070:0.010311:0.010255:0.010311:0.005155:0.005285:0.004024:0.005044:0.005230:0.010311:0.010255:0.010311:0.005007:0.005230:0.010311:0.004006:0.004024:0.010311:0.010255:0.005230:0.005230:0.010070:0.005230:0.010311:0.010255:0.005230:0.010070:0.016486:0.005340:0.005155
The profitability of the pharmaceutical industry can be best understood by looking at several aspects :@0.120984:0.506091:0.944310:0.506091:0.944310:0.491470:0.120984:0.491470:0.011479:0.010311:0.010255:0.005230:0.010070:0.006231:0.010070:0.005415:0.004024:0.005230:0.010311:0.010255:0.004024:0.004024:0.004024:0.005230:0.009068:0.005230:0.010070:0.005415:0.005230:0.005230:0.010311:0.010051:0.005230:0.010311:0.010051:0.010311:0.006175:0.015540:0.010311:0.009272:0.010255:0.010070:0.005230:0.004024:0.009272:0.010311:0.004006:0.005230:0.004024:0.010311:0.010255:0.010311:0.009272:0.005155:0.006287:0.009068:0.005230:0.009272:0.010070:0.010311:0.005155:0.010311:0.010311:0.005211:0.010311:0.010255:0.009272:0.005230:0.005230:0.010311:0.010255:0.010311:0.010051:0.006231:0.009272:0.005230:0.010311:0.010051:0.010311:0.005155:0.010311:0.009087:0.005230:0.004024:0.010311:0.010255:0.009458:0.004024:0.010311:0.010255:0.005230:0.010311:0.005155:0.005100:0.009272:0.010311:0.009031:0.010311:0.006175:0.010311:0.004043:0.005230:0.010311:0.009272:0.010255:0.010311:0.009272:0.005007:0.009272:0.005155
of its underlying economic structure. First, demand for pharmaceuticals has been strong and has grown for :@0.060472:0.528611:0.944663:0.528611:0.944663:0.513990:0.060472:0.513990:0.010070:0.005415:0.005823:0.003839:0.005230:0.009068:0.005823:0.010311:0.010255:0.010311:0.010255:0.006231:0.004024:0.009068:0.004024:0.010311:0.010441:0.005823:0.010070:0.009272:0.010311:0.010255:0.010311:0.015448:0.003876:0.009272:0.005823:0.009068:0.005230:0.006231:0.010311:0.009031:0.005230:0.010311:0.006175:0.010125:0.005044:0.005823:0.011331:0.003987:0.006231:0.009068:0.005230:0.005044:0.005823:0.010311:0.010051:0.015503:0.010311:0.010051:0.010311:0.005601:0.005415:0.010070:0.006045:0.005823:0.010311:0.010255:0.010311:0.006009:0.015503:0.010311:0.009272:0.010255:0.010070:0.005230:0.004024:0.009272:0.010311:0.004006:0.009272:0.005823:0.010311:0.010051:0.009272:0.005823:0.010311:0.010255:0.010311:0.010051:0.006399:0.009068:0.005230:0.006231:0.010311:0.010051:0.010311:0.005804:0.010311:0.010255:0.010070:0.005823:0.010311:0.010255:0.009068:0.005619:0.010311:0.006175:0.010311:0.013111:0.010311:0.005601:0.005415:0.010311:0.006009:0.005155
decades. Between 1990 and 2003, there was a 12.5% annual increase in spending on prescription drugs in :@0.060472:0.551155:0.944291:0.551155:0.944291:0.536534:0.060472:0.536534:0.010311:0.010255:0.009272:0.010311:0.010255:0.010311:0.009272:0.005007:0.005415:0.012295:0.010311:0.005155:0.013148:0.010311:0.010255:0.010311:0.005396:0.010311:0.010255:0.010311:0.010255:0.005230:0.010311:0.010255:0.010311:0.005396:0.010311:0.010255:0.010311:0.010255:0.005044:0.005415:0.005230:0.010311:0.010051:0.006231:0.010070:0.005415:0.013111:0.010311:0.009272:0.005396:0.010311:0.005396:0.010070:0.010311:0.005155:0.010311:0.016356:0.005415:0.010311:0.010255:0.010311:0.010255:0.010311:0.004006:0.005415:0.004024:0.010311:0.009272:0.006175:0.010311:0.010088:0.009272:0.010311:0.005396:0.004024:0.010311:0.005155:0.009272:0.010311:0.010311:0.010311:0.010237:0.004024:0.010311:0.010255:0.005415:0.010311:0.010255:0.005415:0.010070:0.006231:0.010311:0.009272:0.009272:0.006175:0.004117:0.010033:0.005230:0.004024:0.010311:0.010255:0.005415:0.010311:0.006175:0.010125:0.010459:0.009068:0.005415:0.003839:0.010070:0.005155
the United States. This growth was driven by favorable demographics. As people grow older, they tend to :@0.060472:0.573817:0.944143:0.573817:0.944143:0.559197:0.060472:0.559197:0.005230:0.010311:0.010255:0.006435:0.013297:0.010311:0.004006:0.005230:0.010311:0.010255:0.006435:0.012295:0.005230:0.010070:0.005230:0.010311:0.009031:0.005230:0.006231:0.011479:0.010311:0.004006:0.009272:0.006231:0.010459:0.006045:0.010311:0.013074:0.005230:0.010311:0.006398:0.013111:0.010311:0.009272:0.006398:0.010311:0.006175:0.004265:0.009068:0.010311:0.010255:0.006435:0.010311:0.009031:0.006435:0.005415:0.010070:0.009068:0.010311:0.006175:0.010311:0.010311:0.004006:0.010311:0.006398:0.010311:0.010255:0.015503:0.010311:0.010255:0.006231:0.010311:0.010255:0.010311:0.004006:0.009272:0.009272:0.005230:0.006231:0.012295:0.009272:0.006435:0.010311:0.010255:0.010311:0.010255:0.004024:0.010311:0.006398:0.010311:0.006175:0.010311:0.013111:0.006435:0.010311:0.004006:0.010311:0.010255:0.006231:0.005230:0.006435:0.005230:0.010070:0.010311:0.009031:0.006435:0.005230:0.010311:0.010255:0.010311:0.006398:0.005230:0.010070:0.005155
need and consume more prescription medicines, and the population in most advanced nations has been :@0.060472:0.596337:0.944372:0.596337:0.944372:0.581717:0.060472:0.581717:0.010311:0.010255:0.010311:0.010255:0.007232:0.010311:0.010255:0.010070:0.007232:0.009272:0.010311:0.010255:0.009272:0.010070:0.015503:0.010311:0.007010:0.015503:0.010070:0.006045:0.010311:0.007214:0.010311:0.006368:0.010311:0.009031:0.009272:0.006231:0.004024:0.010311:0.005155:0.004117:0.010255:0.010070:0.007232:0.015503:0.010311:0.010255:0.004024:0.009272:0.004024:0.010311:0.010255:0.009068:0.005230:0.007232:0.010311:0.010255:0.010070:0.007028:0.005230:0.010311:0.010255:0.007232:0.010311:0.010255:0.010311:0.010255:0.004024:0.010070:0.005230:0.004024:0.010311:0.010255:0.007232:0.004024:0.010311:0.007010:0.015503:0.010311:0.009272:0.005007:0.007232:0.010311:0.010255:0.009068:0.010311:0.010255:0.009272:0.010311:0.010255:0.007232:0.010311:0.010051:0.005230:0.004024:0.010311:0.010255:0.009272:0.007028:0.010311:0.010255:0.009272:0.007232:0.010311:0.010255:0.010311:0.009847:0.005155
growing older as the post–World War II baby boom generation ages. Looking forward, projections suggest :@0.060472:0.618857:0.944219:0.618857:0.944219:0.604237:0.060472:0.604237:0.010459:0.006045:0.010311:0.013074:0.004024:0.010311:0.010441:0.006231:0.010311:0.004006:0.010311:0.010255:0.006231:0.006231:0.010311:0.009031:0.006231:0.005230:0.010311:0.010051:0.006231:0.010311:0.010255:0.009068:0.005406:0.009877:0.018118:0.010070:0.006231:0.004024:0.010070:0.005823:0.018118:0.010070:0.006045:0.006027:0.005230:0.005044:0.006231:0.010311:0.010255:0.010311:0.009031:0.006231:0.010311:0.010255:0.010311:0.015448:0.006064:0.010459:0.010311:0.010255:0.010070:0.006231:0.010311:0.005155:0.004117:0.010255:0.010311:0.006194:0.010070:0.010459:0.010070:0.009272:0.005044:0.006231:0.010311:0.010255:0.010070:0.009458:0.004024:0.010070:0.010459:0.006027:0.005230:0.010311:0.006175:0.013148:0.010311:0.006175:0.010311:0.005044:0.006231:0.010311:0.006175:0.010125:0.004210:0.010311:0.009272:0.005155:0.004117:0.010255:0.010311:0.009031:0.006231:0.009272:0.010070:0.010311:0.010441:0.010311:0.009272:0.004803:0.005155
that spending on prescription drugs will increase at between 10 and 11% annually through till 2013. :@0.060472:0.641377:0.875108:0.641377:0.875108:0.626756:0.060472:0.626756:0.005230:0.010311:0.010255:0.005044:0.005230:0.009272:0.010311:0.010255:0.010311:0.010255:0.004024:0.010070:0.010459:0.005230:0.010311:0.010051:0.005230:0.010311:0.006175:0.010311:0.009272:0.009087:0.006231:0.003839:0.010311:0.005155:0.004117:0.010255:0.010311:0.005155:0.010311:0.006250:0.010070:0.010459:0.009068:0.005230:0.013111:0.004024:0.004024:0.004024:0.005230:0.004024:0.010311:0.009272:0.006175:0.010311:0.010311:0.009272:0.010311:0.005155:0.010311:0.005230:0.005230:0.010311:0.010051:0.005230:0.013111:0.010311:0.010255:0.010311:0.005155:0.010311:0.010311:0.005211:0.010311:0.010255:0.010311:0.005155:0.010311:0.010107:0.016486:0.005081:0.010311:0.010255:0.010311:0.010255:0.010311:0.004301:0.004024:0.009068:0.005230:0.005230:0.010311:0.006175:0.010311:0.010311:0.010441:0.010070:0.005230:0.005230:0.004024:0.004024:0.004024:0.005230:0.010311:0.010255:0.010311:0.010051:0.005200:0.005155
Second, successful new prescription drugs can be extraordinarily profitable. Lipitor, the cholesterol- :@0.120984:0.663897:0.944852:0.663897:0.944852:0.649276:0.120984:0.649276:0.012295:0.010311:0.009272:0.010255:0.010311:0.010255:0.005230:0.005823:0.009272:0.010311:0.009272:0.009272:0.010255:0.009272:0.009068:0.005230:0.010311:0.004006:0.006027:0.010311:0.010255:0.013111:0.005823:0.010311:0.006175:0.010311:0.009272:0.009272:0.006250:0.004024:0.010311:0.005155:0.004117:0.010255:0.010070:0.006027:0.010311:0.006175:0.010125:0.010311:0.009272:0.005804:0.009272:0.010311:0.010255:0.006027:0.010070:0.010311:0.005990:0.010311:0.009031:0.005230:0.006231:0.010311:0.010255:0.006045:0.010311:0.004006:0.010311:0.010255:0.006231:0.004024:0.004024:0.009068:0.006027:0.010311:0.006175:0.010125:0.005415:0.004024:0.005230:0.010311:0.010255:0.003839:0.010311:0.005155:0.006083:0.010311:0.004006:0.010311:0.004006:0.005230:0.010070:0.006231:0.005044:0.005823:0.005230:0.010311:0.010255:0.006027:0.009068:0.010311:0.010255:0.004024:0.010311:0.009272:0.005155:0.010311:0.006250:0.010311:0.004304:0.006047:0.005155
lowering drug sold by Pfizer, was introduced in 1997, and by 2006, this drug had generated a staggering :@0.060472:0.686417:0.944124:0.686417:0.944124:0.671796:0.060472:0.671796:0.004024:0.010459:0.013111:0.010311:0.006175:0.004117:0.010237:0.010459:0.006843:0.010070:0.006231:0.010070:0.010459:0.006843:0.009272:0.010311:0.004006:0.010311:0.006806:0.010311:0.009031:0.006843:0.012091:0.005230:0.004024:0.009068:0.010311:0.006175:0.005267:0.006843:0.013111:0.010311:0.009272:0.006806:0.004024:0.010311:0.005155:0.006287:0.010311:0.010255:0.010311:0.009272:0.010255:0.010311:0.006806:0.004024:0.010311:0.006806:0.010070:0.010311:0.010255:0.010311:0.005155:0.006899:0.010311:0.010255:0.010070:0.006843:0.010311:0.009031:0.006843:0.010311:0.010255:0.010311:0.010255:0.005230:0.006639:0.005230:0.010311:0.004006:0.009272:0.006843:0.010070:0.006231:0.010070:0.010459:0.006843:0.010311:0.010255:0.010070:0.006639:0.010459:0.010311:0.010255:0.010311:0.006175:0.010125:0.005230:0.010311:0.010255:0.006843:0.010070:0.006843:0.009272:0.005230:0.010070:0.010311:0.010441:0.010070:0.006231:0.004024:0.010070:0.010070:0.005155
$12.5 billion in annual sales for Pfizer. The costs of manufacturing, packing, and distributing Lipitor amounted :@0.060472:0.708937:0.944341:0.708937:0.944341:0.694316:0.060472:0.694316:0.010311:0.010255:0.010311:0.005155:0.010311:0.004451:0.010311:0.004006:0.004024:0.004024:0.004024:0.010311:0.010255:0.004432:0.004024:0.010311:0.004395:0.010311:0.010255:0.010311:0.010255:0.010311:0.004006:0.004432:0.009272:0.010311:0.003851:0.010311:0.009272:0.004210:0.005415:0.010070:0.006231:0.004432:0.012091:0.005415:0.004024:0.009068:0.010311:0.006009:0.005230:0.004228:0.011479:0.010311:0.010051:0.004432:0.009272:0.010311:0.009031:0.005230:0.009068:0.004432:0.010070:0.005230:0.004432:0.015503:0.010311:0.010255:0.010070:0.005230:0.010311:0.009031:0.005230:0.010311:0.006175:0.004117:0.010033:0.010459:0.005044:0.004432:0.010311:0.010255:0.009068:0.009458:0.004024:0.010070:0.010459:0.005044:0.004228:0.010311:0.010255:0.010311:0.004395:0.010311:0.004006:0.009272:0.005230:0.006231:0.004024:0.010311:0.010051:0.005230:0.004024:0.010311:0.010255:0.004432:0.010311:0.004006:0.010311:0.004006:0.005230:0.010311:0.006009:0.004432:0.010070:0.015503:0.010311:0.010255:0.010311:0.005155:0.010311:0.009903:0.005155
to only about 10% of revenues. Pfizer spent close to $500 million on promoting Lipitor and perhaps as much :@0.060472:0.731457:0.944532:0.731457:0.944532:0.716836:0.060472:0.716836:0.005230:0.010311:0.005007:0.010311:0.010255:0.004024:0.009068:0.005044:0.010311:0.010255:0.010311:0.010255:0.005230:0.005044:0.010311:0.010255:0.016486:0.005081:0.010070:0.005230:0.005044:0.006231:0.010311:0.009031:0.010311:0.010255:0.010311:0.010255:0.009272:0.005230:0.005044:0.012091:0.005415:0.004024:0.009068:0.010311:0.006175:0.005081:0.009272:0.010311:0.010255:0.010311:0.005007:0.005044:0.009272:0.004024:0.010311:0.009272:0.010051:0.005044:0.005230:0.010311:0.005007:0.010311:0.010255:0.010311:0.010255:0.004840:0.015503:0.004024:0.004024:0.004024:0.004024:0.010311:0.010255:0.005044:0.010311:0.010255:0.005044:0.010311:0.006175:0.010311:0.015336:0.010311:0.005155:0.004117:0.010255:0.010459:0.005044:0.010311:0.004006:0.010311:0.004006:0.005230:0.010070:0.006231:0.005044:0.010311:0.010255:0.010311:0.005007:0.010311:0.010255:0.006231:0.010311:0.010051:0.010311:0.009031:0.005044:0.010311:0.009272:0.005007:0.015503:0.010311:0.009272:0.010051:0.005155
again on maintaining a sales force to sell the product. That still left Pfizer with a gross profit of perhaps $10 :@0.060472:0.753977:0.944421:0.753977:0.944421:0.739356:0.060472:0.739356:0.010311:0.010441:0.010311:0.004006:0.010311:0.005601:0.010311:0.010051:0.005619:0.015503:0.010311:0.004006:0.010070:0.005230:0.010311:0.004006:0.010311:0.004006:0.010311:0.010441:0.005619:0.010070:0.005619:0.009068:0.010311:0.004006:0.010311:0.009272:0.005396:0.005415:0.010311:0.006009:0.009272:0.010311:0.005396:0.005230:0.010311:0.005601:0.009272:0.010311:0.004006:0.004024:0.005415:0.005230:0.010311:0.010255:0.005619:0.010070:0.006231:0.010070:0.010311:0.010255:0.009272:0.005230:0.005044:0.005415:0.011479:0.010311:0.010255:0.005044:0.005619:0.009068:0.005731:0.004024:0.004024:0.004024:0.005619:0.004024:0.010311:0.005155:0.005285:0.005619:0.012091:0.005415:0.004024:0.009068:0.010311:0.006175:0.005471:0.013297:0.004024:0.005230:0.010311:0.005601:0.010311:0.005396:0.010459:0.006045:0.010311:0.009272:0.009272:0.005601:0.010070:0.006231:0.010070:0.005415:0.003839:0.005230:0.005619:0.010070:0.005230:0.005619:0.010311:0.010051:0.006045:0.010311:0.010255:0.010311:0.009272:0.005601:0.010311:0.010255:0.010070:0.005155
billion. Since the drug is protected from direct competition by a 20- year patent, Pfizer has a temporary :@0.060472:0.776675:0.944558:0.776675:0.944558:0.762054:0.060472:0.762054:0.010311:0.004006:0.004024:0.004024:0.004024:0.010311:0.010255:0.005230:0.007844:0.012295:0.004024:0.010311:0.009272:0.010255:0.007844:0.005230:0.010311:0.010255:0.007844:0.010070:0.006231:0.010070:0.010459:0.007844:0.004024:0.009068:0.007844:0.010311:0.006175:0.010125:0.005230:0.010311:0.009272:0.005155:0.010311:0.010107:0.007640:0.005230:0.006231:0.010070:0.015503:0.007844:0.010311:0.004006:0.006045:0.010311:0.009272:0.005007:0.007844:0.009068:0.010311:0.015448:0.010311:0.010311:0.005211:0.004024:0.005230:0.004024:0.010311:0.010051:0.007844:0.010311:0.009031:0.007844:0.010311:0.007807:0.010311:0.010561:0.006249:0.007861:0.009068:0.010311:0.010051:0.006231:0.007844:0.010311:0.010051:0.005230:0.010311:0.010255:0.005044:0.005230:0.007844:0.012091:0.005415:0.004024:0.009068:0.010311:0.006009:0.007844:0.010311:0.010255:0.009068:0.007844:0.010311:0.007603:0.005230:0.010070:0.015503:0.010311:0.010255:0.006231:0.010070:0.006231:0.009068:0.005155
monopoly and can charge a high price. Once the patent expires, which is scheduled to occur in 2010, other :@0.060472:0.799195:0.944854:0.799195:0.944854:0.784574:0.060472:0.784574:0.015503:0.010311:0.010255:0.010311:0.010255:0.010311:0.004006:0.009068:0.005415:0.010311:0.010255:0.010311:0.005396:0.009272:0.010311:0.010255:0.005415:0.009272:0.010311:0.010255:0.006045:0.010311:0.010255:0.005415:0.010311:0.005396:0.010311:0.004006:0.010459:0.010311:0.005396:0.010070:0.006231:0.004024:0.009272:0.010311:0.005155:0.005285:0.014502:0.010311:0.009272:0.010255:0.005230:0.005230:0.010311:0.010255:0.005230:0.010311:0.010255:0.005230:0.010311:0.010255:0.005230:0.005415:0.010311:0.009031:0.010311:0.004006:0.006231:0.010311:0.009272:0.005155:0.005471:0.013111:0.010311:0.004006:0.009272:0.010311:0.005396:0.004024:0.009272:0.005415:0.009272:0.009272:0.010311:0.010255:0.010311:0.010255:0.004024:0.010311:0.010255:0.005415:0.005230:0.010311:0.005396:0.010311:0.009272:0.009272:0.010051:0.006231:0.005415:0.004024:0.010311:0.005396:0.010311:0.010051:0.010311:0.010255:0.005839:0.005442:0.010311:0.005155:0.010311:0.010107:0.006045:0.005155
firms will be able to produce “generic” versions of Lipitor and the price will fall—typically by 80% within a year. :@0.060472:0.821715:0.944852:0.821715:0.944852:0.807094:0.060472:0.807094:0.005415:0.003839:0.006231:0.015503:0.009068:0.004432:0.013111:0.004024:0.004210:0.004024:0.004432:0.010311:0.010255:0.004432:0.010311:0.010255:0.004024:0.010311:0.004395:0.005230:0.010311:0.004395:0.010311:0.006175:0.010311:0.010311:0.010051:0.009272:0.010311:0.004395:0.006045:0.010459:0.010311:0.010255:0.010311:0.006175:0.004117:0.009031:0.006231:0.004432:0.009068:0.010311:0.006175:0.009272:0.004117:0.010237:0.010311:0.009272:0.004395:0.010070:0.005230:0.004432:0.010070:0.004024:0.010311:0.004006:0.005230:0.010311:0.006175:0.004469:0.010311:0.010255:0.010311:0.004395:0.005230:0.010311:0.010051:0.004432:0.010311:0.006175:0.004117:0.009272:0.010237:0.004432:0.013111:0.004024:0.004024:0.004024:0.004432:0.005415:0.010311:0.004006:0.004440:0.018545:0.005230:0.009068:0.010311:0.004006:0.009272:0.010311:0.004006:0.004210:0.009068:0.004432:0.010459:0.009068:0.004432:0.010311:0.010255:0.016486:0.004469:0.013111:0.004024:0.005230:0.010311:0.004006:0.010459:0.004432:0.010311:0.004395:0.009068:0.010311:0.010255:0.006231:0.005003:0.005155
Competing firms can produce drugs that are similar (but not identical) to a patent- protected drug. :@0.120984:0.844235:0.944764:0.844235:0.944764:0.829614:0.120984:0.829614:0.013297:0.010311:0.015448:0.010311:0.010311:0.005211:0.004024:0.010070:0.010459:0.006639:0.005415:0.003839:0.006231:0.015503:0.009068:0.006843:0.009272:0.010311:0.010255:0.006843:0.010070:0.006231:0.010070:0.010311:0.010255:0.009272:0.010311:0.006806:0.010311:0.006175:0.010125:0.010459:0.009068:0.006843:0.005230:0.010311:0.010051:0.005230:0.006843:0.010070:0.006231:0.010311:0.006806:0.009272:0.004024:0.015503:0.003839:0.004024:0.010311:0.006175:0.006880:0.006231:0.010311:0.010051:0.005230:0.006843:0.010311:0.010255:0.005044:0.006843:0.004024:0.010311:0.010255:0.010311:0.005155:0.004117:0.009272:0.010255:0.004024:0.006231:0.006639:0.005230:0.010311:0.006602:0.010311:0.006806:0.010311:0.010255:0.005230:0.010311:0.010255:0.005618:0.006249:0.006853:0.010070:0.006231:0.010311:0.005155:0.010125:0.009272:0.005230:0.010311:0.010255:0.006843:0.010070:0.006231:0.010070:0.010311:0.005007:0.005155
Drug firms patent a specific molecule, and competing firms can patent similar, but not identical, molecules :@0.060472:0.866755:0.944400:0.866755:0.944400:0.852134:0.060472:0.852134:0.013297:0.006231:0.010311:0.010441:0.006027:0.005230:0.004024:0.006045:0.015503:0.009272:0.006231:0.010311:0.010255:0.005230:0.010070:0.010311:0.005155:0.006287:0.010311:0.006194:0.009272:0.010311:0.010051:0.009068:0.004024:0.005415:0.004024:0.009272:0.006027:0.015503:0.010311:0.004006:0.010605:0.009272:0.010311:0.004006:0.010311:0.005155:0.006287:0.010311:0.010255:0.010311:0.006194:0.009272:0.010070:0.015503:0.010070:0.010311:0.005155:0.004117:0.010255:0.010459:0.006027:0.005415:0.003839:0.006045:0.015503:0.009272:0.006231:0.009272:0.010311:0.010255:0.006231:0.010311:0.010051:0.005230:0.010311:0.010255:0.005230:0.006027:0.009272:0.004024:0.015503:0.004024:0.004024:0.010311:0.006175:0.005267:0.006231:0.010311:0.010051:0.005230:0.006231:0.010311:0.010255:0.005230:0.006231:0.004024:0.010311:0.010255:0.010070:0.005230:0.004024:0.009272:0.010311:0.004006:0.005230:0.006027:0.015503:0.010311:0.004006:0.010311:0.009272:0.010255:0.004024:0.010311:0.009272:0.005155
that have a similar pharmacological effect. Thus Lipitor does have competitors in the market for cholesterol :@0.060472:0.889270:0.944013:0.889270:0.944013:0.874649:0.060472:0.874649:0.005230:0.010311:0.010255:0.005044:0.005823:0.010311:0.010255:0.009068:0.010311:0.005804:0.010070:0.005823:0.009272:0.004024:0.015503:0.004024:0.004024:0.010311:0.006009:0.005823:0.010311:0.010255:0.010311:0.006009:0.015503:0.010311:0.009272:0.010255:0.004024:0.010311:0.010441:0.004024:0.009272:0.010311:0.003802:0.005823:0.010070:0.005230:0.005230:0.010311:0.009031:0.005230:0.005044:0.005619:0.011479:0.010311:0.010255:0.009068:0.005619:0.010311:0.004006:0.010311:0.004006:0.005230:0.010311:0.006175:0.005879:0.010311:0.010255:0.010311:0.009031:0.005823:0.010311:0.010255:0.009068:0.010311:0.005804:0.009272:0.010070:0.015503:0.010311:0.010051:0.005230:0.004024:0.005230:0.010311:0.006175:0.009105:0.005823:0.004024:0.010070:0.005823:0.005230:0.010311:0.010051:0.005619:0.015503:0.010311:0.006009:0.009458:0.010070:0.005044:0.005619:0.005415:0.010070:0.006231:0.005619:0.009272:0.010070:0.010311:0.004006:0.010311:0.009272:0.005155:0.010311:0.006250:0.010311:0.003802:0.005155
lowering drugs, such as Zocor sold by Merck and Crestor sold by AstraZeneca. But these competing drugs :@0.060472:0.911790:0.944640:0.911790:0.944640:0.897169:0.060472:0.897169:0.004024:0.010459:0.013111:0.010311:0.006175:0.004117:0.010237:0.010311:0.005804:0.010311:0.006175:0.010125:0.010459:0.009068:0.005044:0.005823:0.009272:0.010311:0.009272:0.010051:0.005823:0.010311:0.009031:0.005619:0.011331:0.010237:0.009272:0.010311:0.006009:0.005823:0.009272:0.010311:0.004006:0.010311:0.005804:0.010311:0.008846:0.005823:0.015114:0.010311:0.006175:0.009272:0.009272:0.005879:0.010311:0.010255:0.010070:0.005823:0.013297:0.006231:0.010311:0.009031:0.005230:0.010311:0.006009:0.005619:0.009272:0.010311:0.004006:0.010311:0.005804:0.010311:0.009031:0.005823:0.012295:0.009068:0.005230:0.006231:0.010311:0.011257:0.010070:0.010771:0.010311:0.009272:0.010255:0.005044:0.005823:0.012295:0.010311:0.005007:0.005619:0.005230:0.010311:0.010255:0.009272:0.010070:0.005823:0.009272:0.010070:0.015503:0.010311:0.010255:0.005230:0.003839:0.010311:0.010255:0.005823:0.010070:0.006231:0.010070:0.010311:0.009031:0.005155
CASE STUDY 3: :@0.167144:0.285799:0.326204:0.285799:0.326204:0.269907:0.167144:0.269907:0.014695:0.014110:0.013485:0.013485:0.005604:0.013525:0.012316:0.014493:0.014695:0.013304:0.005604:0.011308:0.006833:0.005604
The Pharmaceutical Industry:@0.326379:0.285885:0.559346:0.285885:0.559346:0.270106:0.326379:0.270106:0.012316:0.010079:0.008849:0.005039:0.011268:0.010079:0.008869:0.006712:0.015682:0.008849:0.008940:0.008869:0.010079:0.005604:0.005664:0.009051:0.008869:0.005604:0.005261:0.006450:0.010079:0.010079:0.010079:0.007841:0.005644:0.007035:0.010079
 :@0.559279:0.285799:0.564883:0.285799:0.564883:0.269907:0.559279:0.269907:0.005604
 :@0.167144:0.304328:0.172747:0.304328:0.172747:0.288436:0.167144:0.288436:0.005604
Week :@0.083048:0.278433:0.136419:0.278433:0.136419:0.263812:0.083048:0.263812:0.017506:0.010311:0.010311:0.010088:0.005155
5-6 :@0.093731:0.293684:0.125534:0.293684:0.125534:0.279063:0.093731:0.279063:0.010280:0.006289:0.010079:0.005155